Cargando…

Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice

With more than 7,000 new HIV infections daily worldwide, there is an urgent need for non-vaccine biomedical prevention (nBP) strategies that are safe, effective, and acceptable. Clinical trials have demonstrated that pre-exposure prophylaxis (PrEP) with antiretrovirals (ARVs) can be effective at pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallay, Philippe A., Chatterji, Udayan, Kirchhoff, Aaron, Gandarilla, Angel, Gunawardana, Manjula, Pyles, Richard B., Marzinke, Mark A., Moss, John A., Baum, Marc M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589224/ https://www.ncbi.nlm.nih.gov/pubmed/28880948 http://dx.doi.org/10.1371/journal.pone.0184303

Ejemplares similares

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice
por: Gallay, Philippe A., et al.
Publicado: (2018)

Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc
por: Vincent, Kathleen Listiak, et al.
Publicado: (2018)

Highly synergistic drug combination prevents vaginal HIV infection in humanized mice
por: Baum, Marc M., et al.
Publicado: (2020)

Global Expression of Molecular Transporters in the Human Vaginal Tract: Implications for HIV Chemoprophylaxis
por: Gunawardana, Manjula, et al.
Publicado: (2013)

Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis
por: Gunawardana, Manjula, et al.
Publicado: (2022)

Cultivated Vaginal Microbiomes Alter HIV-1 Infection and Antiretroviral Efficacy in Colonized Epithelial Multilayer Cultures
por: Pyles, Richard B., et al.
Publicado: (2014)

Acute antagonism in three-drug combinations for vaginal HIV prevention in humanized mice
por: Gallay, Philippe A., et al.
Publicado: (2023)

Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial
por: Vincent, Kathleen L., et al.
Publicado: (2018)

Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis
por: Gunawardana, Manjula, et al.
Publicado: (2020)

Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a Reinfection
por: Chatterji, Udayan, et al.
Publicado: (2016)

The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice
por: Bobardt, Michael, et al.
Publicado: (2020)

Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis
por: Gunawardana, Manjula, et al.
Publicado: (2022)

Both Cyclophilin Inhibitors and Direct-Acting Antivirals Prevent PKR Activation in HCV-Infected Cells
por: Bobardt, Michael, et al.
Publicado: (2014)

The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action
por: Gallay, Philippe A., et al.
Publicado: (2015)

Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175
por: Gallay, Philippe A., et al.
Publicado: (2016)

The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate
por: Bobardt, Michael, et al.
Publicado: (2019)

Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model
por: Smith, James M., et al.
Publicado: (2017)

Development and Evaluation of an Enzyme-Linked Immunosorbent Assay for Dengue Capsid
por: Selvarajah, Suganya, et al.
Publicado: (2012)

HCV Core Residues Critical for Infectivity Are Also Involved in Core-NS5A Complex Formation
por: Gawlik, Katarzyna, et al.
Publicado: (2014)

The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice
por: Gallay, Philippe, et al.
Publicado: (2019)

Antiretroviral Pre-exposure Prophylaxis Prevents Vaginal Transmission of HIV-1 in Humanized BLT Mice
por: Denton, Paul W, et al.
Publicado: (2008)

Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production
por: Phillips, Sandra, et al.
Publicado: (2015)

A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
por: Kuo, Joseph, et al.
Publicado: (2019)

Systemic Administration of Antiretrovirals Prior to Exposure Prevents Rectal and Intravenous HIV-1 Transmission in Humanized BLT Mice
por: Denton, Paul W., et al.
Publicado: (2010)

Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120
por: Binley, James M, et al.
Publicado: (2007)

Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120
por: Binley, James M, et al.
Publicado: (2006)

Mucoadhesive Vaginal Discs based on Cyclodextrin and Surfactants for the Controlled Release of Antiretroviral Drugs to Prevent the Sexual Transmission of HIV
por: Notario-Pérez, Fernando, et al.
Publicado: (2020)

Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints
por: Gunawardana, Manjula, et al.
Publicado: (2021)

Rectal bleeding due to rectal erosion of vaginal mesh
por: Ratneswaren, Anenta, et al.
Publicado: (2015)

Clinical SARS-CoV-2 Kinetic Profiles Are Dependent on the Viral Strain and Host Vaccination Status
por: Gunawardana, Manjula, et al.
Publicado: (2022)

HSV Neutralization by the Microbicidal Candidate C5A
por: de Witte, Lot, et al.
Publicado: (2011)

Effect of semen and seminal amyloid on vaginal transmission of simian immunodeficiency virus
por: Münch, Jan, et al.
Publicado: (2013)

Early SARS-CoV-2 dynamics and immune responses in unvaccinated participants of an intensely sampled longitudinal surveillance study
por: Gunawardana, Manjula, et al.
Publicado: (2022)

Cultivated Human Vaginal Microbiome Communities Impact Zika and Herpes Simplex Virus Replication in ex vivo Vaginal Mucosal Cultures
por: Amerson-Brown, Megan H., et al.
Publicado: (2019)

Clinical SARS-CoV-2 Kinetic Profiles Are Dependent on the Viral Strain and Host Vaccination Status
por: Gunawardana, Manjula, et al.
Publicado: (2022)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings
por: Thurman, Andrea Ries, et al.
Publicado: (2019)

Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action
por: Ceña-Diez, Rafael, et al.
Publicado: (2016)

Commensal Bacteria Modulate Innate Immune Responses of Vaginal Epithelial Cell Multilayer Cultures
por: Rose, William A., et al.
Publicado: (2012)

The Development of Vaginal Microbicides for the Prevention of HIV Transmission
por: Weber, Jonathan, et al.
Publicado: (2005)

Pharmaceutical Vehicles for Vaginal and Rectal Administration of Anti-HIV Microbicide Nanosystems
por: Mesquita, Letícia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qfhdt3p8jurdh6ol1614smt5rb